Lung Cancer (Diagnosis) Clinical Trials

20 recruiting

Lung Cancer (Diagnosis) Trials at a Glance

20 actively recruiting trials for lung cancer (diagnosis) are listed on ClinicalTrialsFinder across 6 cities in 10 countries. The largest study group is Not Applicable with 11 trials, with the heaviest enrollment activity in Wuhan, Guangzhou, and Brussels. Lead sponsors running lung cancer (diagnosis) studies include AdventHealth, Baohui Han, and Abramson Cancer Center at Penn Medicine.

Browse lung cancer (diagnosis) trials by phase

Treatments under study

About Lung Cancer (Diagnosis) Clinical Trials

Looking for clinical trials for Lung Cancer (Diagnosis)? There are currently 20 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Lung Cancer (Diagnosis) trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Lung Cancer (Diagnosis) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 20 trials

Recruiting
Not Applicable

Blood Based Risk Evaluation With AI for Targeted Primary Health Care in Early Lung Cancer Detection

Lung Cancer (Diagnosis)
Vejle Hospital1,000 enrolled2 locationsNCT07552584
Recruiting
Not Applicable

Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.

Lung Cancer (Diagnosis)
bioAffinity Technologies Inc.2,063 enrolled3 locationsNCT07168993
Recruiting
Not Applicable

Prospective Multicentre Study for the Application of Telomere Measurement Technology as a Tool for Lung Cancer Diagnosis

Lung Cancer (Diagnosis)Health Adult SubjectsPatient
Grupo Español de Investigación en Diagnóstico y Tratamiento Hipertemprano de Enfermedades (GeDiTPhe)1,200 enrolled12 locationsNCT07465848
Recruiting

Study of Risk Factors and Prediction of Blood Clots After Lung Cancer Surgery

Lung Cancer (Diagnosis)Venous Thromboembolism (VTE)Deep Vein Thrombosis (DVT)
The First Hospital of Jilin University900 enrolled1 locationNCT07439991
Recruiting
Phase 1Phase 2

EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors

SarcomaCancerLeukaemia+2 more
Essen Biotech83 enrolled1 locationNCT07410676
Recruiting
Not Applicable

Discrimination of N2a and N2b by EBUS-TBNA: is a Change of the Needle Necessary?

Lung Cancer (Diagnosis)
University of Vienna30 enrolled1 locationNCT07418450
Recruiting

Validation of High-Throughput Large-Format Tissue Preprocessing for Lung and Colorectal Cancer

Lung Cancer (Diagnosis)CRC (Colorectal Cancer)
Nanfang Hospital, Southern Medical University1,000 enrolled1 locationNCT07239063
Recruiting

Noninvasive Detection of Lung Nodule Malignancy Using cfDNA Fragmentomics

Lung Cancer (Diagnosis)Fragmentomics
Baohui Han240 enrolled1 locationNCT07399210
Recruiting
Not Applicable

Effect of Apneic Oxygenation of the Non-ventilated Lung During Lung Cancer Surgery.

Lung Cancer (Diagnosis)
Osijek University Hospital56 enrolled1 locationNCT07393490
Recruiting
Not Applicable

Immune Cells Role in Lung Cancer and Their Use in Anticancer Immunotherapies and Inflammatory Lung Disease

Lung Cancer (Diagnosis)Chronic Obstructive Pulmonary DiseaseSarcoidosis+2 more
Université Catholique de Louvain425 enrolled1 locationNCT07384897
Recruiting
Not Applicable

Antrodia Cinnamomea Extract Effects on Lung Cancer Patients' Quality of Life During Chemotherapy

Lung Cancer (Diagnosis)
Tri-Service General Hospital40 enrolled1 locationNCT07241182
Recruiting

Molecular Phenotyping of Primitive Lung Cancer and Metastatic Site

NSCLCLung Cancer (Diagnosis)
European Institute of Oncology25 enrolled1 locationNCT07325864
Recruiting

A Study to Explore the Early Subjective Evaluation and Objective Recovery in Lung Cancer Patients Undergoing Sublobar Resection Versus Lobectomy

Lung Cancer (Diagnosis)Sublobar ResectionLobectomy
The First Affiliated Hospital of Guangzhou Medical University300 enrolled1 locationNCT07288710
Recruiting
Not Applicable

Accuracy Between Transthoracal Needle Aspiration (TTNA) Techniques in Suspected Lung Cancer Patients

Lung Cancer (Diagnosis)Biopsy, Fine-Needle/Methods
Gadjah Mada University54 enrolled1 locationNCT07255950
Recruiting

Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots

Breast CancerProstate CancerLung Cancer (Diagnosis)
AdventHealth200 enrolled1 locationNCT07231159
Recruiting
Not Applicable

Telehealth Collaborative Care Model (CoCM) in Lung Cancer

Lung Cancer (Diagnosis)AnxietyDepression in Adults
Abramson Cancer Center at Penn Medicine30 enrolled1 locationNCT07102147
Recruiting
Not Applicable

Intraoperative Paravertebral Block and Postoperative Complications

Lung Cancer (Diagnosis)Video-assisted Thoracoscopic Surgery (VATS)Pulmonary Infections+8 more
Tongji Hospital500 enrolled1 locationNCT07211529
Recruiting
Not Applicable

SBU-RESET: RElaxation, Stress Reduction and Epigenetics Trial in Cancer Survivors

Colon CancerLung Cancer (Diagnosis)Lung Adenocarcinoma+8 more
Barbara Nemesure100 enrolled1 locationNCT07161713
Recruiting

Predicting Immunotherapy Response and Survival of Lung Cancer Patients Using Artificial Intelligence and Radiomics (Radiology-AI-Lung)

Lung Cancer (Diagnosis)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology400 enrolled1 locationNCT07059923
Recruiting

Multi-omics Detection Techniques for Differentiating Benign and Malignant Pulmonary Nodules

Lung Cancer (Diagnosis)Pulmonary Nodule Persistent
Zhao Jun150 enrolled1 locationNCT07047573